Enanta Pharmaceuticals, Inc. (ENTA)
13.41
-0.40
(-2.90%)
USD |
NASDAQ |
May 15, 16:00
13.46
+0.06
(+0.41%)
After-Hours: 20:00
Enanta Pharmaceuticals Profit Margin (Quarterly) : -76.29% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cyclerion Therapeutics, Inc. | -- |
| Keros Therapeutics, Inc. | -6.46K% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Amgen, Inc. | 21.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.47% |
| Return on Assets | -19.85% |
| Return on Invested Capital | -20.87% |
| Gross Profit Margin (Quarterly) | 92.95% |
| Operating Margin (Quarterly) | -69.07% |
| Return on Net Operating Assets | -76.78% |